Skip to content

Comparision of Spinal anaesthesia with Hyperbaric Levobupivacaine and Hyperbaric Ropivacaine

Comparison between Intrathecal Hyperbaric Levobupivacaine versus Hyperbaric Ropivacaine for below umbilical surgeries: a Randomized controlled trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/11/047003
Enrollment
120
Registered
2022-11-03
Start date
Unknown
Completion date
Unknown
Last updated
2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

None listed

Sponsors

All India Institute of Medical Sciences Bibinagar
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Age 18 -70 years 2. ASA grade 1 and ASA grade 2 patients coming for elective below Umbilical surgeries

Exclusion criteria

Exclusion criteria: 1. Emergency surgery 2. Known bleeding diathesis 3. Neuromuscular disease 4. Local skin infections 5. Severe back deformities 6. Raised intracranial pressure 7. Severe Stenotic valvular lesions 8. Cognitive dysfunction 9. Pregnant patients

Design outcomes

Primary

MeasureTime frame
1.To compare intrathecal hyperbaric Levobupivacaine and hyperbaric Ropivacaine, on the time required for first rescue analgesia in patients undergoing below umbilicus surgeries. 2. To compare intrathecal hyperbaric Levobupivacaine and hyperbaric Ropivacaine, for their effects on motor blockade in patients undergoing below umbilicus surgeries. Timepoint: Every 15 minutes until the time required for the first rescue analgesia.

Secondary

MeasureTime frame
1 To compare the effects of intrathecal hyperbaric Levobupivacaine and hyperbaric Ropivacaine on the hemodynamic in patients undergoing below umbilicus surgeries.Timepoint: every 5 minutes during the intraoperative period

Countries

India

Contacts

Public ContactGarre Sandeep

All India Institute of Medical Sciences - Bibinagar

drsandeep189@gmail.com9989421851

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026